Billions are Spent on Fake Medicines by Europeans

According to a Pfizer-sponsored survey, western Europeans spend an estimated 10.5 billion Euros on counterfeit medicines in a year. These medicines contain the wrong or even toxic ingredients that resulted in health threat worldwide, particularly in poor countries, according to the World Health Organization.

The most prescription-only drugs without a prescription are bought by Germans and Italians either by the Internet or on overseas trips, in nightclubs, in shops and via friends. One in five of the 14,000 people surveyed, equating to


Auxilium to Start Review of Pfizer Drug Xiaflex

In what would come as welcome news to patients suffering from Dupuytren's Contracture, Pfizer Inc. and Auxilium Pharmaceutical Inc. have announced that the scientific/technical review procedure of the drug Xiaflex (collagenase clostridium histolyticum) would begin January 21, 2010, following notification of the successful completion of the validation phase of the Market Authorization Application (MAA) for the drug, by European Medicines Agency.


U.S. FDA Still Not Satisfied of Pfizer vaccine

The U. S. Food and Drug Administration have still not given a green signal to Prevnar vaccine of Pfizer. This children’s vaccine has been developed to fight pneumonia and meningitis, but it seems that the regulator is not happy with the vaccine just as yet.

Pfizer obtained this vaccine from Wyeth, after acquiring Wyeth for $67 billion. Now, Pfizer wants FDA’s acceptance to market Prevnar 13 as a vaccine for infants and toddlers.


Pfizer Units to Pay over $165 Million in Damages over Menopause Medicine

A jury orders has asked Wyeth and Pharmacia & Upjohn Pfizer units to pay over $165 Million in damages to women who contacted cancer after long terms use of the drug manufacturer's Prempro hormone-replacement drug, combination of two hormone medicines actually, as has been confirmed by the lawyers representing the women.

Since 2006, juries have been meeting to settle lawsuits over the the ill-effects of the menopause medicines, and since then, Pfizer's Wyeth subsidiary has been slapped with as many as 5 "bad


Pfizer's Prevnar to be Considered Effective and Safe - FDA

The US Food and Drug Administration on Wednesday, after a round of voting, announced that the new version of children's medicine Prevnar should be considered both effective and safe for administration in children and infants to treat "pneumococcal illnesses".

After some experts expressed concerns over the fact that clinical tests' data was not enough to determine if the new version was more effective than the original one, the FDA advisory board voted, and the drug won the agency's approval, 10-1.



Subscribe to RSS - Pfizer